Pharmacokinetic and Efficacy Profile Intranasal Scopolamine Spray

NCT02155309 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

63

Enrollment

INDUSTRY

Sponsor class

Stopped Business reason

Conditions

Motion Sickness

Interventions

DRUG: Scopolamine
DRUG: Placebo

Sponsor

Repurposed Therapeutics, Inc.